Enabling high-fidelity personalised pharmaceutical tablets through multimaterial inkjet 3D printing with a water-soluble excipient
Source abstract
Abstract
Additive manufacturing offers manufacture of personalised pharmaceutical tablets through design freedoms and material deposition control at an individual voxel level. This control goes beyond geometry and materials choices: inkjet based 3D printing enables the precise deposition (10–80 μm) of multiple materials, which permits integration of precise doses with tailored release rates; in the meanwhile, this technique has demonstrated its capability of high-volume personalised production. In this paper we demonstrate how two dissimilar materials, one water soluble and one insoluble, can be co-printed within a design envelope to dial up a range of release rates including slow (0.98 ± 0.04 mg/min), fast (4.07 ± 0.25 mg/min) and multi-stepped (2.17 ± 0.04 mg/min then 0.70 ± 0.13 mg/min) dissolution curves. To achieve this, we adopted poly-4-acryloylmorpholine (poly-ACMO) as a new photocurable water-soluble carrier and demonstrated its contemporaneous deposition with an insoluble monomer. The water soluble ACMO formulation with aspirin incorporated was successfully printed and cured under UV light and a wide variety of shapes with material distributions that control drug elution was successfully fabricated by inkjet based 3D printing technique, suggesting its viability as a future personalised solid dosage form fabrication routine.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Additive Manufacturing and 3D Printing Technologies · Innovative Microfluidic and Catalytic Techniques Innovation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. Žitnik · Clin. Chem. Lab. Med. · 2018 · 56 · 198110.1515/cclm-2018-0181 ↗
2. Hamburg · N. Engl. J. Med. · 2010 · 363 · 30110.1056/NEJMp1006304 ↗
3. Yamamoto · J. Personalized Med. · 2022 · 12 · 44410.3390/jpm12030444 ↗
4. Kang · Langmuir · 2024 · 40 · 657110.1021/acs.langmuir.4c00213 ↗
5. Ma · Colloids Surf. B Biointerfaces · 2023 · 23110.1016/j.colsurfb.2023.113571 ↗
6. Ma · Sensor Actuat A-Phys · 2023 · 351
7. Robles-Martinez · Pharmaceutics · 2019 · 1110.3390/pharmaceutics11060274 ↗
8. Windolf · Pharmaceutics · 2022 · 14 · 93110.3390/pharmaceutics14050931 ↗
9. Khaled · J. Contr. Release · 2015 · 217 · 30810.1016/j.jconrel.2015.09.028 ↗
10. Chen · Addit. Manuf. · 2020 · 34
11. Patel · Adv. Drug Deliv. Rev. · 2021 · 174 · 36910.1016/j.addr.2021.04.020 ↗
12. Auriemma · Mol. · 2022 · 27 · 278410.3390/molecules27092784 ↗
13. Ragelle · Adv. Drug Deliv. Rev. · 2021 · 17810.1016/j.addr.2021.113990 ↗
14. Elkaseer · Addit. Manuf. · 2022 · 60
15. Saleh · Adv. Mater. Technol. · 2017 · 210.1002/admt.201700134 ↗
16. Kansara · J. Mech. Phys. Solid. · 2023 · 18010.1016/j.jmps.2023.105382 ↗
17. He · Adv. Sci. · 2021 · 8
18. Borandeh · Adv. Drug Deliv. Rev. · 2021 · 173 · 34910.1016/j.addr.2021.03.022 ↗
19. Clark · Int. J. Pharm. · 2020 · 57810.1016/j.ijpharm.2019.118805 ↗
20. He · Adv. Ther. · 2020 · 3
21. van der Merwe · Pharm. Times · 2020 · 12 · 393
22. Beneke · Mol · 2009 · 14 · 260210.3390/molecules14072602 ↗
23. Majid Khan · J. Contr. Release · 1999 · 57 · 19710.1016/S0168-3659(98)00122-9 ↗
24. Wahab · Pharmazie · 2011 · 66 · 677
25. P. K. Parmar, S. G. Rao, A. K. Bansal, https://doi-org.nottingham.idm.oclc.org/10.1080/17425247.2021.1873946 2021, 18, 907..10.1080/17425247.2021.1873946 ↗
26. Wilfert · J. Polym. Sci. Part A Polym. Chem. · 2014 · 52 · 28710.1002/pola.27002 ↗
27. Choi · Int. J. Mol. Sci. · 2022 · 23 · 949110.3390/ijms23169491 ↗
28. Jadach · J. Pharmaceut. Sci. · 2022 · 111 · 125010.1016/j.xphs.2021.12.024 ↗
29. Farley · Angew. Chem., Int. Ed. · 2021 · 6010.1002/anie.202106794 ↗
30. Seoane-Viaño · Adv. Drug Deliv. Rev. · 2021 · 174 · 55310.1016/j.addr.2021.05.003 ↗
31. Gyles · Can. Vet. J. · 2019 · 60 · 1033
32. Abousalman-Rezvani · Rezvani Polym. Chem. · 2022 · 13 · 594010.1039/D2PY00992G ↗
33. Wang · Int. J. Environ. Res. Publ. Health · 2019 · 16 · 215310.3390/ijerph16122153 ↗
34. Dokoumetzidis · Pharm. Res. (N. Y.) · 2006 · 23 · 256
35. Gao · J. Pharmaceut. Sci. · 2011 · 100 · 493410.1002/jps.22673 ↗
36. Osterberg · Int. J. Toxicol. · 2003 · 22 · 37710.1177/109158180302200507 ↗
37. Mau · Prog. Biomed. Eng. · 2021 · 310.1088/2516-1091/ac1731 ↗
38. Siddiqui · Int. J. Pharmaceut. Sci. Rev. Res. · 2010 · 4 · 87
39. Chakma · Angew. Chem. Int. Ed. · 2022 · 135
40. Siefker · Macromolecules · 2022 · 55 · 250910.1021/acs.macromol.1c02472 ↗
41. Salmi · Materials · 2021 · 14 · 19110.3390/ma14010191 ↗
42. Ge · Int. J. Extrem. Manuf. · 2020 · 210.1088/2631-7990/ab8d9a ↗
43. Krueger · Med. J. Aust. · 2022 · 216 · 6410.5694/mja2.51381 ↗
44. Kyobula · J. Contr. Release · 2017 · 261 · 20710.1016/j.jconrel.2017.06.025 ↗
45. Lion · Pharm. Times · 2021 · 13 · 1679